增强CT用于临床诊断腹部肿瘤腹腔转移的价值分析与随机对照评价

发布时间：2019-05-18 18:09

【摘要】：目的研究增强CT用于临床诊断腹部肿瘤腹腔转移的价值。方法于2014年1月-2015年4月期间选取我院影像科CT室接诊的腹部肿瘤转移患者60例。按诊断方法不同分为观察组(增强CT扫描)和对照组(常规CT扫描),以手术病理检查结果为准,对比两组诊断正确率、最小种植灶面积、不良反应发生率。结果观察组诊断正确率为93.33%,较对照组的(83.33%)高,P0.05;观察组诊断出最小种植灶为(1.00×0.70)mm2,较对照组的(2.72×1.80)mm2小,观察组种植灶平均宽度、长度均小于对照组,P0.05;观察组不良反应发生率(3.33%)与对照组(0.00%)比较差异不显著,P0.05。结论增强CT用于临床诊断腹部肿瘤腹腔转移有以下优势:对小种植灶具更高敏感性,显著提高诊断准确率;不良反应发生率低,安全性高。
[Abstract]:Objective to study the value of enhanced CT in the diagnosis of abdominal metastasis of abdominal tumors. Methods from January 2014 to April 2015, 60 patients with abdominal tumor metastasis were selected from CT department of imaging department. According to the different diagnostic methods, the two groups were divided into observation group (enhanced CT scan) and control group (routine CT scan). According to the results of surgical and pathological examination, the diagnostic accuracy, the minimum area of implantation focus and the incidence of adverse reactions were compared between the two groups. Results the diagnostic accuracy of the observation group was 93.33%, which was higher than that of the control group (83.33%) (P0.05). The minimum implantation foci diagnosed in the observation group were (1.00 脳 0.70) mm2, which were smaller than those in the control group (2.72 脳 1.80) mm2. The average width and length of the implantation foci in the observation group were smaller than those in the control group (P0.05). There was no significant difference in the incidence of adverse reactions between the observation group (3.33%) and the control group (0.00%). Conclusion enhanced CT has the following advantages in clinical diagnosis of abdominal metastasis of abdominal tumors: it is more sensitive to small implantation foci and significantly improves the diagnostic accuracy, and the incidence of adverse reactions is low and the safety is high.
【作者单位】：三峡大学第二人民医院肿瘤医院放化疗科;三峡大学第二人民医院肿瘤医院影像科;
【分类号】：R730.44;R735.2

【相似文献】